Posted on 2/14/20
Fortress Biotech Prices Series A Preferred Stock Offering
NEW YORK, Feb. 11, 2020 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (Common Stock: Nasdaq: FBIO) (Preferred Stock: Nasdaq: FBIOP), an innovative biopharmaceutical company focused on identifying, . . .
Posted on 2/14/20
Tonix Pharmaceuticals Closes $7.5M Public Offering
NEW YORK, Feb. 11, 2020 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) a clinical-stage biopharmaceutical company, announced today the closing of its previously announced . . .
Posted on 2/14/20
Agile Therapeutics Enters into up to $35M Loan Facility with Perceptive Advisors
PRINCETON, N.J., Feb. 10, 2020 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced that it has entered into a senior . . .
Posted on 2/14/20
Seelos Therapeutics Prices $5M Public Offering of Common Stock
NEW YORK, Feb. 10, 2020 (GLOBE NEWSWIRE) -- Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous . . .
Posted on 2/14/20
High Focus Centers Opens New Outpatient Treatment Facility In Norwalk, CT
High Focus Centers, a Joint Commission accredited provider of outpatient behavioral healthcare treatment for individuals suffering with mental health, substance use, and eating disorders, announced today . . .
Posted on 2/14/20
All-Care Physical Therapy Partners with the Ivy Rehab Network
Ivy Rehab Physical Therapy, a national leader in outpatient musculoskeletal rehabilitative services, is proud to announce that All-Care Physical Therapy ("All-Care") has joined its network of . . .
Posted on 2/13/20
Acorda Therapeutics Provides Business Update
ARDSLEY, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics, Inc. (Nasdaq: ACOR) today provided a business update and reported its financial results for the fourth quarter and full year ended December . . .
Posted on 2/13/20
Merck's Keytruda Helps Treat an Aggressive Form of Breast Cancer
Chalk up another win for Keytruda, Merck's (NYSE:MRK) cancer drug that seems to be able to be useful in treating almost every type of cancer it's . . .
Posted on 2/13/20
Cleveland Physical Therapy Associates Joins the Ivy Rehab Network
Ivy Rehab Physical Therapy ("Ivy"), a national leader in outpatient musculoskeletal rehabilitative services with over 220 locations across 11 states, is thrilled to announce that Cleveland . . .
Posted on 2/12/20
BD, Babson Diagnostics Announce Strategic Partnership Agreement
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company and Babson Diagnostics, a transformative diagnostic blood testing company, today announced a long-term . . .
Posted on 2/12/20
Dr. Reddy’s Laboratories to Acquire Select Business Divisions of Wockhardt in India
HYDERABAD, India--(BUSINESS WIRE)--Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY) today announced that it has entered into a definitive agreement with Wockhardt Limited to acquire . . .
Posted on 2/12/20
Professional Physical Therapy Partners with Physitrack over Patient Engagement Technology
NEW YORK--(BUSINESS WIRE)--Professional Physical Therapy, the leading provider of physical, occupational and hand therapy in the Northeastern United States, has announced it has partnered with Physitrack, . . .
Posted on 2/12/20
Why Teladoc Health Stock Popped 21.5% in January
What happenedShares of Teladoc (NYSE:TDOC) climbed 21.5% in January, according to data from S&P Global Market Intelligence, after the telemedicine technology stock announced an exciting $600 . . .
Posted on 2/12/20
Johnson & Johnson Is Racing Against Time to Develop the First Coronavirus Vaccine
Over the past several weeks, there's nothing that has monopolized the news quite so much as the terrifying and deadly coronavirus. The illness has claimed over . . .
Posted on 2/12/20
Johnson & Johnson Announces Partnership With U.S. government to Accelerate Coronavirus Vaccine Development
Johnson & Johnson (NYSE:JNJ) announced on Tuesday afternoon that subsidiary Janssen Pharmaceutical will be working together with the U.S. government to expedite the development of a . . .
Posted on 2/11/20
Volastra Therapeutics Launches with $12 Million in Seed Financing
NEW YORK--(BUSINESS WIRE)--Volastra Therapeutics, a biotechnology company developing novel therapies for the treatment of metastatic cancers, launches with a $12 million financing. Polaris Partners led the . . .
Posted on 2/11/20
Bristol-Myers Squibb Stock Is Too Cheap to Ignore
Bristol-Myers Squibb's (NYSE:BMY) decision to acquire Celgene in a cash and stock transaction valued at $74 billion wasn't particularly well-received. For instance, one of the company's . . .
Posted on 2/11/20
Johnson & Johnson Submits FDA Application for Multiple Myeloma Drug
Johnson & Johnson (NYSE:JNJ) subsidiary Janssen announced on Monday that it had filed a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration . . .
Posted on 2/10/20
OncoSec Announces Closing of the CGP/Sirtex Transaction
SAN DIEGO & PENNINGTON, N.J.--(BUSINESS WIRE)--OncoSec Medical Incorporated (NASDAQ:ONCS), a company developing late-stage intratumoral cancer immunotherapies, today announced that, following shareholder approval, the proposed strategic investment . . .
Posted on 2/10/20
Better Choice Company Announces Intention to Form an Animal Health & Wellness Joint Venture with cbdMD
NEW YORK--(BUSINESS WIRE)--Better Choice Company, Inc. (OTCQB: BTTR), an animal health and wellness company, today announced the execution of a non binding letter of intent to . . .
Posted on 2/10/20
M Science Receives SFC Approval to Advise on Securities in Hong Kong and Establishes First Asia-Pacific Office
NEW YORK & HONG KONG--(BUSINESS WIRE)--M Science, the pioneer in data-driven research and analytics, today announced that M Science Hong Kong Limited has received its Type . . .
Posted on 2/10/20
ADMA Biologics Prices Upsized $82.3M Public Offering of Common Stock
RAMSEY, N.J. and BOCA RATON, Fla., Feb. 06, 2020 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing . . .
Posted on 2/10/20
ADMA Biologics Announces Proposed $75 Million Public Offering of Common Stock
RAMSEY, N.J. and BOCA RATON, Fla., Feb. 06, 2020 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing . . .
Posted on 2/10/20
Tonix Pharmaceuticals Prices $7.5 million Public Offering
NEW YORK, Feb. 07, 2020 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, announced today the pricing . . .
Posted on 2/10/20
Bellerophon Announces 1-for-15 Reverse Stock Split
WARREN, N.J., Feb. 07, 2020 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq: BLPH), a clinical-stage biotherapeutics company, today announced the filing of a certificate of amendment . . .
New York
